Stimulation of α4β2 nicotinic acetylcholine receptors inhibits β- amyloid toxicity

Brain Research

Volumn 792, Issue 2, 1998, Pages 331-334

  Kihara, T ^a   Shimohama, S ^a   Urushitani, M ^a   Sawada, H ^a   Kimura, J ^a   Kume, T ^a   Maeda, T ^a   Akaike, A ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

4 2; amyloid; Alzheimer's disease; Cortex; Nicotine

Indexed keywords

ALPHA BUNGAROTOXIN; ALPHA4,BETA2 NICOTINIC RECEPTOR ANTAGONIST; AMYLOID BETA PROTEIN; DIHYDRO BETA ERYTHROIDINE; NICOTINIC AGENT; UNCLASSIFIED DRUG; ALKALOID; AZOCINE DERIVATIVE; BUNGAROTOXIN; CYTISINE; NEUROPROTECTIVE AGENT; NICOTINE; NICOTINIC RECEPTOR; QUINOLIZINE DERIVATIVE;

AMYLOID NEUROPATHY; AMYLOIDOSIS; ANIMAL CELL; ARTICLE; DRUG MECHANISM; NERVE CELL NECROSIS; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; RAT; RECEPTOR DOWN REGULATION; ALZHEIMER DISEASE; ANIMAL; BRAIN CORTEX; CELL CULTURE; CHEMISTRY; CYTOLOGY; DRUG EFFECT; FETUS; METABOLISM; NERVE CELL; PHYSIOLOGY;

ALKALOIDS; ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; ANIMALS; AZOCINES; BUNGAROTOXINS; CELLS, CULTURED; CEREBRAL CORTEX; DIHYDRO-BETA-ERYTHROIDINE; FETUS; NEURONS; NEUROPROTECTIVE AGENTS; NICOTINE; NICOTINIC AGONISTS; QUINOLIZINES; RATS; RECEPTORS, NICOTINIC;

EID: 0032507506     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(98)00138-3     Document Type: Article

References (19)

1. Akaike A., Tamura Y., Sato Y., Ozaki K., Matsuoka R., Miuraand S., Yoshinaga T. Cholecystokinin-induced protection of cultured cortical neurons against glutamate neurotoxicity. Brain Res. 557:1991;303-307.
2. 2+ influx induced by beta-amyloid peptide 25-35 in cultured hippocampal neurons results from network excitation. J. Neurobiol. 26:1995;325-338.
3. Citron M., Westaway D., Xia W., Carlson G., Diehl T., Levesque G., Johnson Wood K., Lee M., Seubert P., Davis A., Kholodenko D., Motter R., Sherrington R., Perry B., Yao H., Strome R., Lieberburg I., Rommens J., Kim S., Schenk D., Fraser P., St George Hyslopand P., Selkoe D.J. Mutant presenilins of Alzheimer's disease increase production of 42-residue amyloid beta-protein in both transfected cells and transgenic mice. Nat. Med. 3:1997;67-72.
4. Hardyand J.A., Higgins G.A. Alzheimer's disease: the amyloid cascade hypothesis. Science. 256:1992;184-185.
5. +-dependent glutamate uptake in rat hippocampal astrocyte cultures. J. Neurochem. 67:1996;277-286.
6. Kihara T., Shimohama S., Sawada H., Kimura J., Kume T., Kochiyama H., Maedaand T., Akaike A. Nicotinic receptor stimulation protects neurons against beta-amyloid toxicity. Ann. Neurol. 42:1997;159-163.
7. Kume T., Kouchiyama H., Kaneko S., Maeda T., Kaneko S., Akaike A., Shimohama S., Kihara T., Kimura J., Wadaand K., Koizumi S. BDNF prevents NO mediated glutamate cytotoxicity in cultured cortical neurons. Brain Res. 756:1997;200-204.
8. Le W.D., Colom L.V., Xie W.J., Smith R.G., Alexianuand M., Appel S.H. Cell death induced by beta-amyloid 1-40 in MES 23.5 hybrid clone: the role of nitric oxide and NMDA-gated channel activation leading to apoptosis. Brain Res. 686:1995;49-60.
9. Parpura-Gill A., Beitzand D., Uemura E. The inhibitory effects of beta-amyloid on glutamate and glucose uptakes by cultured astrocytes. Brain Res. 754:1997;65-71.
10. Perry E.K., Morris C.M., Court J.A., Cheng A., Fairbairn A.F., McKeith I.G., Irving D., Brownand A., Perry R.H. Alteration in nicotine binding sites in Parkinson's disease, Lewy body dementia and Alzheimer's disease: possible index of early neuropathology. Neuroscience. 64:1995;385-395.
11. Salomon A.R., Marcinowski K.J., Friedlandand R.P., Zagorski M.G. Nicotine inhibits amyloid formation by the beta-peptide. Biochemistry. 35:1996;13568-13578.
12. Selkoe D.J. The molecular pathology of Alzheimer's disease. Neuron. 6:1991;487-498.
13. Shimohama S., Akaikeand A., Kimura J. Nicotine-induced protection against glutamate cytotoxicity: nicotinic cholinergic receptor-mediated inhibition of nitric oxide formation. Ann. New York Acad. Sci. 777:1996;356-361.
14. Shimohama S., Ogawa N., Tamura Y., Akaike A., Tsukahara T., Iwataand H., Kimura J. Protective effect of nerve growth factor against glutamate-induced neurotoxicity in cultured cortical neurons. Brain. Res. 632:1993;296-302.
15. Shimohama S., Taniguchi T., Fujiwaraand M., Kameyama M. Changes in nicotinic and muscarinic cholinergic receptors in Alzheimer-type dementia. J. Neurochem. 46:1986;288-293.
16. Wada E., Wada K., Boulter J., Deneris E., Heinemann S., Patrickand J., Swanson L.W. Distribution of alpha 2, alpha 3, alpha 4, and beta 2 neuronal nicotinic receptor subunit mRNAs in the central nervous system: a hybridization histochemical study in the rat. J. Comp. Neurol. 284:1989;314-335.
17. Whitehouse P.J., Kalaria R.N. Nicotinic receptors and neurodegenerative dementing diseases: basic research and clinical implications. Alzheimer Dis. Assoc. Disord. 9:1995;3-5. Suppl. 2.
18. Whitehouse P.J., Martino A.M., Antuono P.G., Lowenstein P.R., Coyle J.T., Priceand D.L., Kellar K.J. Nicotinic acetylcholine binding sites in Alzheimer's disease. Brain Res. 371:1986;146-151.
19. Yankner B.A., Duffyand L.K., Kirschner D.A. Neurotrophic and neurotoxic effects of amyloid beta protein: reversal by tachykinin neuropeptides. Science. 250:1990;279-282.